Dr. Gerald Louis Denardo M.D.
Hematologist-Oncologist | Hematology & Oncology
1508 Alhambra Blvd Sacramento CA, 95816About
Dr. Gerald Denardo is a hematologist oncologist practicing in Sacramento, CA. Dr. Denardo specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
University of California 1957
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Nuclear MedicineAmerican Board of Nuclear MedicineABNM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- 67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma.
- Milestones in the development of Lym-1 therapy.
- Phage library-derived human anti-TETA and anti-DOTA ScFv for pretargeting RIT.
- Abnormal peripheral distribution of Thallium-201 due to arteriosclerosis.
- Abnormal peripheral distribution of Thallium-201 due to arteriosclerosis.
- Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
- A new era for radiolabeled antibodies in cancer?
- Tribute to David A. Goodwin and Claude F. Meares, recipients of the Immunomedics Science Award.
- Effect of 67Cu-2IT-BAT-Lym-1 therapy on BCL-2 gene and protein expression in a lymphoma mouse model.
- Development of a hyperimmune anti-MUC-1 single chain antibody fragments phage display library for targeting breast cancer.
- Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics.
- Strategies for developing effective radioimmunotherapy for solid tumors.
- Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A.
- 67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma.
- Critical Lym-1 binding residues on polymorphic HLA-DR molecules.
Dr. Gerald Louis Denardo M.D.'s Practice location
Dr. Gerald Louis Denardo M.D.'s reviews
Write ReviewRecommended Articles
- What are the Stages of Multiple Myeloma?
This is the uncommon type of cancer that forms in plasma cells. A type of white blood cells found in the body, plasma cells, identify and battle germs and infections that attack the body.In multiple myeloma patients, the healthy plasma cells are overtaken by cancer cells. This reduces the number of...
- The Link Between Melatonin and Lymphoma
There’s always room for improvement when it comes to the experience and outcomes of cancer treatment. Fortunately, scientists are constantly researching new, better ways to do so. Although standard treatment remains mostly the same for now, the medical community is making great strides in...
- Seven-year-old Lymphoma Ninja Warrior Fights Through 500 Days of Chemo
In some ways, Von Kleiv is an ordinary 7-year-old boy. He goes to Welch Elementary School in Dover, Delaware. He’s in second grade. He’s getting into karate, and just broke his first wooden board at his first demonstration. People know him as a boy warrior with a strong spirit. He is optimistic,...
- Little Boy Tugs at Heartstrings of Entire Community: Be the Match!
Danny Feltwell, a young six-year-old boy, was diagnosed with T-cell lymphoblastic lymphoma when he was just two years old. After undergoing countless procedures and just four months from being considered fully cured, Danny relapsed and had to be re-hospitalized. The doctors found that a large tumor...
- Inspirational Blood Cancer Survivors
Different forms of blood cancer are responsible for claiming the third most lives out of all the types of cancer. Additionally, there are currently no known preventative treatments for blood cancers, and the disease also impacts children and young people more than any other form of cancer.When it...
- Can Multiple Myeloma be Asymptomatic?
Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...
Nearby Providers
- Dr. Li F. Hu MD1600 Eureka Rd Roseville CA 95661
- Dr. Donald S Colbourn MD2 Medical Plaza Roseville CA 95661
- Dr. Frank Tze Hsieh MD1600 Eureka Rd Roseville CA 95661
- Dr. Ram Lalchandani M.D.6555 Coyle Ave Carmichael CA 95608
- Dr. Scott D Christensen M.D.4501 X St Sacramento CA 95817
- Dr. Rajeswari Chellappah M.D.2 MEDICAL PLAZA DR ROSEVILLE CA 95661